Edition:
United Kingdom

Guerbet SA (GRBT.PA)

GRBT.PA on Paris Stock Exchange

52.60EUR
1:31pm BST
Change (% chg)

€0.40 (+0.77%)
Prev Close
€52.20
Open
€52.50
Day's High
€52.80
Day's Low
€51.70
Volume
3,585
Avg. Vol
12,893
52-wk High
€87.65
52-wk Low
€50.00

Chart for

About

Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents... (more)

Overall

Beta: 0.50
Market Cap(Mil.): €630.06
Shares Outstanding(Mil.): 12.50
Dividend: 0.85
Yield (%): 1.63

Financials

  GRBT.PA Industry Sector
P/E (TTM): 19.16 29.67 32.21
EPS (TTM): 2.72 -- --
ROI: 5.31 13.44 13.05
ROE: 11.27 15.16 14.90

BRIEF-Guerbet Expects 2018 Revenue In-Line With 2017

* FOR 2018, EXPECTS REVENUE IN-LINE WITH 2017 AT CONSTANT EXCHANGE RATES

18 Apr 2018

BRIEF-Guerbet Q1 Revenue Stable At 196.5 Million Euros

* Q1 REVENUE EUR 196.5 MILLION VERSUS EUR 197.3 MILLION YEAR AGO

18 Apr 2018

BRIEF-Guerbet Partners With Lausanne’S CHUV And CET To Launch Clinical Study

* PARTNERS WITH LAUSANNE’S CHUV AND CET TO LAUNCH A CLINICAL STUDY

13 Apr 2018

BRIEF-Guerbet FY EBITDA Increased By 22.4 Percent To 130 Million Euros

* FY NET INCOME EUR 46.2 MILLION VERSUS EUR 28.9 MILLION YEAR AGO

27 Mar 2018

BRIEF-Guerbet: FY Revenue At Constant Exchange Rates Increases To 812.4 Million Euros

* REG-GUERBET : 2017 REVENUE AT CONSTANT EXCHANGE RATES: €812.4 MILLION; +4.7%

15 Feb 2018

BRIEF-Guerbet Updates On MHLW Decision In Japan

* HAS IMMEDIATELY PROCEEDED TO REQUESTED REVISION OF PRECAUTIONS FOR MAGNESCOPE Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

06 Dec 2017

Earnings vs. Estimates